Capricor Comments on Briefing Materials Ahead of July 29 FDA Advisory Committee Meeting for Deramiocel
Go back to Capricor Comments on Briefing Materials Ahead of July 29 FDA Advisory Committee Meeting for Deramiocel| Capricor Therapeutics, Inc. (NASDAQ: CAPR) | Delayed: 9.42 +0.86 (10.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.56 | 52 Week High | $5.40 | |||
| Open | $8.93 | 52 Week Low | $1.88 | |||
| Day High | $9.79 | P/E | N/A | |||
| Day Low | $8.82 | EPS | $0.00 | |||
| Volume | 3,937,422 | |||||
